Hexamethonium, a forgotten drug in relation to “new” concepts in the management of heart failure
- 1 August 1989
- journal article
- editorial
- Published by Elsevier in American Heart Journal
- Vol. 118 (2) , 426-427
- https://doi.org/10.1016/0002-8703(89)90213-5
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hopeJournal of the American College of Cardiology, 1988
- Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.Circulation, 1985
- Beneficial effects of long-term beta-blockade in congestive cardiomyopathy.Heart, 1980
- Augmentation of the Plasma Nor-Epinephrine Response to Exercise in Patients with Congestive Heart FailureNew England Journal of Medicine, 1962
- HEXAMETHONIUM IN THE TREATMENT OF HYPERTENSIONThe Lancet, 1954
- THE HEMODYNAMIC EFFECTS OF HYPOTENSIVE DRUGS IN MAN. III. HEXAMETHONIUM 123Journal of Clinical Investigation, 1953
- The Effects of Hexamethonium on Certain Manifestations of Congestive Heart FailureCirculation, 1953
- Treatment of Hypertension by Penta- and Hexa-methonium SaltsBMJ, 1951
- Treatment of Severe Hypertension with Hexamethonium BromideBMJ, 1950
- PENTAMETHONIUM IN HYPERTENSIONThe Lancet, 1950